Cargando…

Allogeneic bone marrow transplantation can suppress established and otherwise chronic collagen-induced arthritis after a nonmyeloablative conditioning regimen employing anti-CD40 ligand monoclonal antibody

Detalles Bibliográficos
Autores principales:	Flierman, R, Morgan, L, van Duivenvoorde, L, de Vries, RRP, Fibbe, WE, Huizinga, TJW, Toes, REM, van Laar, JM
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833778/ http://dx.doi.org/10.1186/ar1137

Ejemplares similares

CD25(+ )regulatory T cells can be used therapeutically in collagen-induced arthritis
por: Morgan, ME, et al.
Publicado: (2004)

Vaccination with TNF-α modulated DCs protects against CIA in an antigen-specific manner
por: van Duivenvoorde, LM, et al.
Publicado: (2004)

CD25(+) regulatory cells from HLA-DQ8 transgenic mice are capable of modulating collagen-induced arthritis
por: Morgan, ME, et al.
Publicado: (2003)

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCP) affects severity of rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2004)

FcγR-mediated uptake and processing of antigen–immunoglobulin complexes by professional antigen-presenting cells
por: de Jong, JMH, et al.
Publicado: (2005)

Fine-specificity of the antibodies against citrullinated protein response is influenced by shared epitope alleles
por: Verpoort, KN, et al.
Publicado: (2007)

Functional regulatory immune responses against human cartilage glycoprotein-39 in health versus proinflammatory responses in rheumatoid arthritis
por: van Bilsen, JHM, et al.
Publicado: (2005)

Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
por: Kanda, Junya, et al.
Publicado: (2011)

What Role Is There for Antithymocyte Globulin in Allogeneic Nonmyeloablative Canine Hematopoietic Cell Transplantation?
por: Diaconescu, Razvan, et al.
Publicado: (2005)

Cellular-based immune modulation in arthritis
por: Toes, REM, et al.
Publicado: (2004)

Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCT
por: van der Velden, Walter J. F. M., et al.
Publicado: (2021)

CD25 regulatory cells are involved in protection from collagen-induced arthritis in both susceptible and non-susceptible mice
por: Morgan, ME, et al.
Publicado: (2002)

Nonmyeloablative Allogeneic Stem-Cell Transplantation for Metastatic Renal Cell Cancer: A Review and Update
por: Erotocritou, P., et al.
Publicado: (2006)

Immunomodulatory effect of unpulsed-immature dendritic cells in collagen-induced arthritis
por: Plence, PL, et al.
Publicado: (2005)

Graft-vs-tumor effect in patients with advanced nasopharyngeal cancer treated with nonmyeloablative allogeneic PBSC transplantation
por: Toh, H C, et al.
Publicado: (2011)

Administration of anti-HER2 antibody after nonmyeloablative allogeneic stem cell transplantation in metastatic breast cancer
por: Banna, G L, et al.
Publicado: (2006)

Fibroblast-like synoviocytes obtained from different joints at different times from one patient show similar invasiveness in vitro
por: Tolboom, TCA, et al.
Publicado: (2003)

Role of IL-10 as a susceptibility factor for rheumatoid arthritis and cardiovascular disease
por: Kurreeman, FAS, et al.
Publicado: (2005)

Kinetics of IL-7 and IL-15 Levels after Allogeneic Peripheral Blood Stem Cell Transplantation following Nonmyeloablative Conditioning
por: De Bock, Muriel, et al.
Publicado: (2013)

Autoantibodies to GPI are predominantly present in extra-articular complications of human rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2003)

Fludarabine and cyclophosphamide provides a nonmyeloablative alternative conditioning regimen with low transplant-related mortality and control of high risk disease
por: Paplham, Pamela, et al.
Publicado: (2014)

Graft-versus-Leukemia Effect of Nonmyeloablative Stem Cell Transplantation
por: Imamura, Masahiro, et al.
Publicado: (2009)

The invasiveness of fibroblast-like synoviocytes is of relevance for the rate of joint destruction in patients with rheumatoid arthritis and is a patient characteristic
por: Tolboom, TCA, et al.
Publicado: (2005)

Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative conditioning
por: Schwaiger, Elisabeth, et al.
Publicado: (2012)

Incidence and Pattern of Graft-versus-Host Disease in Patients Undergoing Allogeneic Transplantation after Nonmyeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin
por: Veltri, Lauren, et al.
Publicado: (2013)

Comparison of Minimal Residual Disease as Outcome Predictor for AML Patients in First Complete Remission Undergoing Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation
por: Walter, Roland B., et al.
Publicado: (2014)

Fibroblast-like synoviocytes from rheumatoid arthritis patients express less flice-inhibitory protein than FLS from osteoarthritis, trauma and prosthesis loosening patie
por: Tolboom, TCA, et al.
Publicado: (2002)

Human cartilage glycoprotein 39-directed T cell responses in health and arthritic diseases
por: Bilsen, JHM van, et al.
Publicado: (2004)

(GT)(n) Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation
por: Køllgaard, Tania, et al.
Publicado: (2016)

PTPN22 as a rheumatoid arthritis susceptibility but not severity gene
por: Wesoly, J, et al.
Publicado: (2005)

High-dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of synovial abnormalities
por: van Oosterhout, M, et al.
Publicado: (2005)

Immune Reconstitution Kinetics following Intentionally Induced Mixed Chimerism by Nonmyeloablative Transplantation
por: Kim, Nayoun, et al.
Publicado: (2015)

Autoantibodies predict progression to rheumatoid arthritis in undifferentiated arthritis: a prospective cohort study
por: van Gaalen, FA, et al.
Publicado: (2003)

Safety and efficacy of a nonmyeloablative pretransplant conditioning regimen using total lymphoid irradiation with volumetric modulated arc therapy in healthy dogs: A pilot study
por: Kim, Sangho, et al.
Publicado: (2021)

Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide
por: Munchel, Ashley, et al.
Publicado: (2011)

A nonmyeloablative chimeric mouse model accurately defines microglia and macrophage contribution in glioma
por: Yu, K., et al.
Publicado: (2018)

High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation
por: Long-Boyle, Janel R, et al.
Publicado: (2010)

Early treatment of recent-onset rheumatoid arthritis patients impairs the effect of HLA class II antigents on the progression of joint destruction
por: Lard, LR, et al.
Publicado: (2001)

In Sections or Otherwise
por: Patterson, J. D.
Publicado: (1904)

Small Split Doses of CD34(+) Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy
por: Yankelevich, Maxim, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3hrhjb6pp7rvm7alopkhp5er2s